Fluoride interactions: From molecules to disease

Current Signal Transduction Therapy

Volumn 2, Issue 3, 2007, Pages 190-213

  Strunecka, Anna ^a   Patocka, Jiri ^b   Blaylock, Russell L ^c   Chinoy, Niloufer J ^d  

^a CHARLES UNIVERSITY   (Czech Republic)

^b UNIVERSITY OF SOUTH BOHEMIA   (Czech Republic)

^c Belhaven College   (United States)

^d GUJARAT UNIVERSITY   (India)

Author keywords

Aluminofluoride complexes; Animal modeling; Fluoride; G proteins; Human exposure; Neurotoxicity

Indexed keywords

ALPHA TOCOPHEROL; ALUMINUM; AMINOFLUORIDE; ASCORBIC ACID; CALCIUM; CYTOKINE; ENZYME; FLUORIDE; GLUTAMIC ACID; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; PHOSPHATE; VITAMIN D;

BEHAVIOR; BLOOD CELL; BLOOD LEVEL; BODY FLUID; BONE CELL; BRAIN; CENTRAL NERVOUS SYSTEM; CHEMICAL INTERACTION; COGNITION; DEVELOPMENT; EMBRYO DEVELOPMENT; ENDOCRINE GLAND; ENDOTHELIUM CELL; ENERGY METABOLISM; ERYTHROCYTE; EXCITOTOXICITY; EXPOSURE; FETUS DEVELOPMENT; FLUOROSIS; GROWTH; HEALTH HAZARD; HEART; HOMEOSTASIS; HUMAN; HYPOMAGNESEMIA; IMMUNE SYSTEM; IN VITRO STUDY; INTELLIGENCE QUOTIENT; KIDNEY CELL; LIVER; LIVER CELL; LUNG ENDOTHELIUM; LYMPHOCYTE; MENTAL DEFICIENCY; MENTAL DISEASE; MICROGLIA; MILK LEVEL; NEPHROTOXICITY; NEUROPATHOLOGY; NEUTROPHIL; NONHUMAN; OSTEOBLAST; OSTEOCLAST; PATHOPHYSIOLOGY; PHOTORECEPTOR CELL; PINEAL BODY; PREGNANCY; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SALIVA LEVEL; SIGNAL TRANSDUCTION; TESTIS; THROMBOCYTE; THYROID GLAND; URINE LEVEL;

EID: 34848886355     PISSN: 15743624     EISSN: None     Source Type: Journal    
DOI: 10.2174/157436207781745300     Document Type: Review

References (331)

1. RAll TW, Sutherland BW. Formation of a cyclic adenine ribonucleotide by tissue particles. J Biol Chem 1958; 232: 1065-76.
2. Sutherland EW, Rail TW, Menon T. Adenyl cylase. I. Distribution, preparation, and properties. J Biol Chem 1962; 237: 1220-27.
3. Gilman AG. G proteins: transducers of receptor-generated signals. Annu Rev Biochem 1987; 56: 615-49.
4. Rodbell M. Nobel lecture. Signal transduction: evolution of an idea. Biosci Rep 1995; 15: 117-33.
5. Strunecká A, Patočka J. Pharmacological and toxicological effects of aluminofluoride complexes. Fluoride 1999; 32: 230-42.
6. Strunecká A, Patočka J. Aluminofluoride Complexes in the Etiology of Alzheimer's disease. Struct Bond 2003; 104: 139-81.
7. Dean HT. The investigation of physiological effects by the "epidemiological method". In: Moulton FR Ed, Fluorine and dental health. Washington, AAAS 1942; 23.
8. Dean HT, Dixon RM, Cohen C. Mottled enamel in Texas. Publ Health Rep 1935; 50: 424.
9. Bryson C. The fluoride deception. New York, A Seven Stories Press 2004; 1-374.
10. Weinstein LH, Davidson A. Fluorides in the environment. Effects on plants and animals. Wallingford, UK, CABI Publishing, CAB International 2003: 1-320.
11. Carlsson A. Current problems relating to the pharmacology and toxicology of fluorides. J Swedish Med Assoc 1978; 14: 1338-92.
12. McClure FJ. A review of fluorine and its physiological effects. Physiol Rev 1933; 13: 277-300.
13. Lebioda L, Zhang E, Lewinski K, Brewer JM. Fluoride inhibition of ycast enolase, crystal structure of the enolase-Mg(2+)-F(-)-Pi complex at 2.6 A resolution. Proteins 1993; 16: 219-25.
14. Antonny B, Chabre M. Characterization of the aluminum and beryllium fluoride species which activate transducin. Analysis of the binding and dissociation kinetics. J Biol Chem 1992; 267: 6710-8.
15. Baykov AA, Fabrichniy IP, Pobjanjoki P, Zyryanov AB, Lahti R. Fluoride effects along the reaction pathway of pyrophosphatase: evidence for a second enzyme. pyrophosphate intermediate. Biochemistry 2000; 39: 11939-47.
16. Heikinheimo P, Tuominen V, Ahonen AK, et al. Toward a quantum-mechanical description of metal-assisted phosphoryl transfer in pyrophosphatase. Proc Natl Acad Sci USA 2001; 98: 3121-26.
17. Lunardi J, Dupuis A, Garin J, et al. Inhibition of H+-transporting ATPase by formation of a tight nucleoside diphosphate-fluoroaluminate complex at the catalytic site. Proc Natl Acad Sci USA 1988; 85: 8958-62.
18. Missiaen L, Wuytack F, De Smedt H, Amant F, Casteels R. AIF4-induced inhibition of the ATPase activity, the Ca2+-transport activity and the phosphoprotein-intermediate formation of plasma-membrane and endo(sarco) plasmic-reticulum Ca2+-transport ATPases in different tissues. Biochem J 1989; 26: 655-60.
19. Bigay J, Deterre P, Pfister C, Chabre M. Fluoride complexes of aluminium or beryllium act on G-proteins as reversibly bound analogues of the gamma phosphate of GTP. EMBO J 1987; 6: 2907-13.
20. Chabre M. Aluminofluoride and beryllofluoride complexes: new phosphate analogues in enzymology. Trends Biochem Sci 1990; 15: 6-10.
21. Strunecká A, Patočka J. Aluminofluoride complexes: A useful tool in laboratory investigations, but a hidden danger for living organisms? In: Shapiro P, Atwood DA Ed, Group 13 Chemistry: Fundamental research, material science and catalysis. Washington, ACS Series 822 2002; 271-82.
22. Wittinghofer A. Aluminum fluoride for molecule of the year. Curr Biol 1997; 7: R682-90.
23. Zakrzewska H, Udała J, Błaszczyk B. In vitro influence of sodium fluoride on ram serum quality and enzyme activities. Fluoride 2002; 35: 153-60.
24. Lau KH, Farley JR, Freeman TK, Baylink DJ. A proposed mechanism of the mitogenic action of fluoride on bone cells. Inhibition of the activity of an osteoblastic acid phosphatase. Metabolism 1989; 38: 858-68.
25. Moonga BS, Pazianas M, Alm AS, et al. Stimulation of a Gs-like protein in the osteoclast inhibits bone resorption but enhances tartrate - resistant acid phosphatase secretion. Biochem Biophys Res Commum 1993; 190: 496-501.
26. Oguro A, Kawase T, Orikasa M. NaF induces early differentiation of marine bone marrow cells along the granulocytic pathway but not the monticytic or preosteoelastic pathway in vitro. Cell Dev Biol Anim 2003; 39: 243-48.
27. Partanen S. Inhibition of human renal acid phosphatases by nephrotoxic micromolar concentrations of fluoride. Exp Toxicol Pathol 2002; 54: 231-37.
28. Arellano M, Malet-Martino M, Martino R, Spector T. 5-Ethynyluracil (GW776): effects on the formation of the toxic catabolites of 5-fluorouracil, fluoroacetate and fluorohydroxypropionic acid in the isolated perfused rat liver model. Br J Cancer 1997; 76: 1170-80.
29. Blackmore PF, Bocckino SB, Waynick LE, Exton JH. Role of a guanine nucleotide-binding regulatory protein in the hydrolysis of hepatocyte phosphatidylinositol 4,5-bisphosphate by calcium-mobilizing hormones and the control of cell calcium. Studies utilizing aluminum fluoride. J Biol Chem 1985; 260: 14477-83.
30. Magnaldo I, Pouyssegur J, Paris S. Thrombin exerts a dual effect on stimulated adenylate cyclase in hamster fibroblasts, an inhibition via a GTP-binding protein and a potentiation via activation of protein kinase C. Biochem J 1988; 253: 711-19.
31. Zhao XL, Wu JH. Actions of sodium fluoride on acetylcholinesterase activities in rats. Biomed Environ Sci 1998; 11: 1-6.
32. Tormanen CD. Substrate inhibition of rat liver and kidney arginase with fluoride. J Inorg Biochem 2003; 93: 243-46.
33. Lando G, Mosca, A, Boners, R, et al. Frequency of butyrylcholinesterase gene mutations in individuals with abnormal inhibition numbers: an Italian-population study. Pharmacogenetics 2003; 13: 265-70.
34. Feig SA, Shohet SB, Nathan DG. Energy metabolism in human erythrocytes. I. Effects of sodium fluoride. J Clin Invest 1971; 50: 1731-37.
35. Shahed AR, Miller A, Allmann DW. Effect of fluorine containing compounds on the activity of glycolytic enzymes in rat hepatocytes. Biochem Biophys Res Commum 1980; 94: 901-08.
36. Nishikimi A, Uekawa N, Yamada M. Involvement of glycolytic metabolism in developmental inhibition of rat two-cell embryos by phosphate. J Exp Zool 2000; 287: 503-09.
37. van Loveren C. Antimicrobial activity of fluoride and its in vivo importance: identification of research questions. Caries Res 2001; 35: 65-70.
38. Large AJ, Arion WJ, Burchell A, Burchell B. Aluminum ions are required for stabilization and inhibition of hepatic microsomal glucose-6-phosphatase by sodium fluoride. J Biol Chem 1986; 261: 101-07.
39. Blackmore PF, Exton JH. Studies on the hepatic calcium-mobilizing activity of aluminum fluoride and glucagon. Modulation by cAMP and phorbol myristate acetate. J Biol Chem 1986; 261: 11056-63.
40. Paris S, Poyssegur J. Further evidence for a phospholipase C-coupled G-protein in hamster fibroblasts. Induction of inositol phosphate formation by fluroaluminate and vanadate inhibition by pertussis toxin. J Biol Chen 1987; 262: 1970-76.
41. Tiger G, Bjorkulund PE, Brannstrom G, Fowler CJ. Multiple actions of fluoride ions upon the phosphoinositide cycle in the rat brain. Brain Res 1990; 531: 93-161.
42. Zhang B, Wu D. Effect of fluoride on proliferation and differentiation in rat and mouse embryo bud cell in vitro. Hua Xi Yi Ke Da Xue Xue Bao 1998; 29: 256-68.
43. Ratz PH, Lattanzio FA. L-type Ca2+ channel desensitization by F- reduces PhE-induced increase in [Ca2+]i but notstress. Am J Physiol 1992; 262: C621-27.
44. Murphy AJ, Hoover JC. Inhibition of the Na,K-ATPase by fluoride Parallels with its inhibition of the sarcoplasmic reticulum CaATPase. J Biol Chem 1992; 267: 16995-7000.
45. Cittanova ML, Estepa L, Bourbouze R, et al. Fluoride ion toxicity in tabbit kidney thick ascending limb cells. Eur J Anaesthesiol 2002; 19: 341-49.
46. Sagi ER, Traub LM, Spiegel AM, Zick Y. Protein kinase C-mediated phosphorylation of retinal rod outer segment membrane proteins. Cell Signal 1989; 1: 519-31.
47. Li L, Fleming N. Aluminum fluoride inhibits phospholipase D activation by a GTP-binding protein-independent mechanism. FEBS Lett 1999; 458: 419-23.
48. Ratz PH, Blackmore PF. Differential activation of rabbit femoral arteries by aluminium fluoride and sodium fluoride. J Pharmacol Exp Ther 1990; 254: 514-20.
49. Lau KH, Baylink DJ. Molecular mechanism of action of fluoride on bone cells. J Bone Miner Res 1998; 13: 1660-67.
50. Saralakumari D, Rao PR. Red blood cell glucose metabolism in human chronic fluoride toxicity. Bull Environ Contain Toxicol 1991; 47: 834-39.
51. Slater EC, Felberg NT, Holler T. The effect of fluoride on the succinic oxidase system. Biochem J 1952; 52: 185-96.
52. Sullivan W. The in vitro and in vivo efects of fluoride on succinic dehydrogenase activity. Fluoride 1969; 2: 168-74.
53. Sternweis PC, Gilman AG. Aluminium: A requirement for activation of the regulatory component of adenylate cyclase by fluoride. Proc Natl Acad Sci USA 1982; 79: 4888-91.
54. Nair BG, Parikh B, Milligan G, Patel TB. Cardiac adenylate cyclase. J Biol Chem 1990; 263: 21317-22.
55. Hrbasova M, Novotny J, Hejnova L, et al. Altered myocardial Gs protein and adenylyl cyclase signaling in rats exposed to chronic hypoxia and normoxic recovery. J Appl Physiol 2003; 94: 2423-32.
56. Boyer JL, Waldo GL, Evans T, et al. Modification of AlF-4- and receptor-stimulated phospholipase C activity by G-protein beta gamma subunits. J Biol Chem 1989; 264: 13917-22.
57. Stohr J, Novotny J, Bourova L, Svoboda P. Modulation of adenylyl cyclase activity in young and adult rat brain cortex. Identification of suramin as a direct inhibitor of adenylyl cyclase. J Cell Mol Med 2005; 9: 940-52.
58. Zhou J, Sims C, Chang CH, et al. Proximal tubular epithelial cells posses a novel 42-kDa guanine nucleotide-binding regulatory protein. Proc Natl Acad Sci USA 1990; 87: 7532-35.
59. Chae HJ, Chae SW, Kang JS, Kim DE, Kim HR. Mechanism of mitogenic effect of fluoride on fetal rat osteoblastic cells: evidence for Shc, Grb2 and P-CREB-dependent pathways. Res Commun Mol Pathol Pharmacol 1999; 105: 185-99.
60. Hashimoto H, Lau KH. Differential effects of bacterial toxins on mitogenic actions of sodium fluoride and those of aluminum fluoride in human TE85 osteosarcoma cells. Mol Cell Biochem 2001; 228: 91-98.
61. Hawkins C, Xu A, Narayanan N. Comparison of the effects of fluoride on the calcium pumps of cardiac and fast skeletal muscle sarcoplasmic reticulum: evidence for tissue-specific qualitative difference in calcium-induced pump conformation. J Biol Chem 1994; 269: 31198-206.
62. Wasner HK, Gebel M, Hucken S, Schaefer M, Kincses M. Two different mechanisms for activation of cyclic PIP synthase: by a G protein or by protein tyrosine phosphorylation. Biol Chem 2000; 381: 145-53.
63. Muto N, Kanoh M, Yamamoto I. Cytidylate cyclase activity is stimulated via activation of a guanine nucleotide-binding protein. Life Sci 1993; 52: 13-20.
64. Caverzasio J, Palmer G, Bonjour JP. Fluoride: Mode of Action. Bone 1998; 22: 585-89.
65. Yatani A, Brown AM. Mechanism of fluoride activation of G protein-gated muscarinic atrial K+ channels. J Biol Chem 1991; 366: 22872-77.
66. Terzic A, Tung RT, Inanobe A, Katada T, Kurachi Y. G proteins activate ATP-sensitive K+ channels by antagonizing ATP-dependent gating. Neuron 1994; 12: 885-93.
67. Wang A, Xia T, Ran P, et al. Effects of selenium and fluoride on apoptosis and lipid peroxidation in human hepatocytes. Zhonghua Yu Fang Yi Xue Za Zhi 2002; 36: 235-38.
68. Refsnes M, Thrane EV, Lag M, Hege Thoresen G, Schwarze PE. Mechanisms in fluoride-induced interleukin-8 synthesis in human lung epithelial cells. Toxicology 2001; 167: 145-58.
69. Hughes BP, Barritt GJ. The stimulation by sodium fluoride of plasma-membrane Ca2+ inflow in isolated hepatocytes. Evidence that a GTP-binding regulatory protein is involved in the hormonal stimulation of Ca2+ inflow. Biochem J 1987; 245: 41-47.
70. Shpetner H, Joly M, Hartley D, Corvera S. Potential sites of PI-3 kinase function in the endocytic pathway revealed by the PI-3 kinase inhibitor, wortmannin. J Cell Biol 1996; 132: 595-605.
71. Goldman R, Granot Y, Zor U. A pleiotropic effect of fluoride on signal transduction in macrophages: is it mediated by GTP-binding proteins? J Basic Clin Physiol Pharmacol 1995; 6: 79-94.
72. Iorio P, Gresele P, Stasi M, et al. Protein kinase C inhibitors enhance G-protein induced phospholipase A2 activation in intact human platelets. FEBS Lett 1996; 381: 244-48.
73. Wessel K, Resch K, Kaever V. Aluminium fluoride enhances phospholipase A2 activity and eicosanoid synthesis in macrophages. Eicosanoids 1989; 2: 223-27.
74. Buckley BJ, Barchowsky A, Dolor RJ, Whorton AR. Regulation of arachidonic acid release in vascular endothelium. Ca(2+)-dependent and -independent pathways. Biochem J 1991: 280(Pt 2): 281-7.
75. Blackmore PF, Lynch CJ, Uhing RJ, et al. Role of guanine nucleotide regulatory proteins and inositol phosphates in the hormone induced mobilization of hepatocyte calcium. Adv Exp Med Biol 1988; 232: 169-82.
76. Strunecka A, El Dessouki NI, Palecek J, et al. The effect of inositol 1,4,5-trisphosphate and inositol 1,4,5-trisphosphorothioate on calcium release and membrane skeleton organization in the human red blood cell. Receptor 1991; 1: 141-54.
77. Chen CC, Chang J, Chen WC. Potentiation of bradykinin-induced inositol phosphates production by cyclic AMP elevating agents and endothelin- 1 in cultured astrocytes. Glia 1996; 16: 210-17.
78. Rendu F, Lebret M, Tenza D, Levy-Tolenado S. How does fluoroaluminate activate human platelets? Biochem J 1990; 265: 343-49.
79. Cao YZ, Reddy PV, Sordillo LM, Hildenbrandt GR, Reddy CC. Evidence for G-protein-dependent and G-protein-independent activation of phospholipase D in lymphocytes. Biochem Biophys Res Commun 1996; 229: 630-34.
80. Lindmar R, Loffelholz K. Phospholipase D in rat myocardium: formation of lipid messengers and synergistic activation by G-protein-and protein kinase C. Biochem Pharmacol 1998; 56: 799-805.
81. Qian Z, Drewes LR. Cross-talk between receptor-regulated phospholipase D and phospholipase C in brain. FASEB J 1991; 5: 315-19.
82. Caverzasio J, Montessuit CH, Bonjour JP. Functional role of Pi transport in osteogenic cells. News Physiol Sci 1996; 11: 119-25.
83. Thomas AB, Hashimoto H, Baylink DJ, Lau KH. Fluoride at mitogenic concentrations increases the steady state phosphotyrosyl phosphorylation level of cellular proteins in human bone cells. J Clin Endocrinol Metab 1996; 81: 2570-78.
84. Martin RB. Ternary hydroxide complexes in neutral solutions of A13+ and F-. Biochem Biophys Res Commun 1988; 155: 1194-200.
85. Strunecká A, Strunecký O, Patočka J. Fluoride plus aluminum: The useful tools in laboratory investigations, but messengers of the false information. Physiol Res 2002; 51: 557-64.
86. Schetinger MRC, Morsch VM, Bohrer D. Aluminum: Interaction with nucleotides and nucleotidasees and analytical aspects of its determination. Struct Bond 2003; 104: 99-137.
87. Schlichting I, Reinstein J. pH influences fluoride coordination number of the AlFx phosphoryl transfer transition state analog. Nat Struct Biol 1999; 8: 721-23.
88. Conley B, Atwood DA. Fluoroaluminate chemistry. Struct Bond 2003; 104: 181-96.
89. Bond AM, Hefter GT. Critical survey of stability constants and related thermodynamic data of fluoride complexes in aqueous solution. IUPAC Chemical Data Series 27. New York, Pergamon Press 1980.
90. Sutherland EW, Robison GA. The role of cyclic AMP in responses to catecholamines and other hormones. Pharmacol Rev 1966; 18: 145-61.
91. Rodbell M. The effects of insulin, lipolytic hormones, and theophylline on glucose transport and metabolism in "ghosts" J Biol Chem 1967; 242: 5751-56.
92. Nielsen TB, Lad PM, Preston MS, et al. Structure of the turkey erythrocyte adenylate cyclase system. Proc Natl Acad Sci USA 1981; 78: 722-26.
93. Morris AJ, Malbon CC. Physiological Regulation of G Protein-Linked Signaling. Physiol Rev 1999; 79: 1373-430.
94. Sondek J, Lambright DG, Noel JP, Hamm HE, Sigler PB. GTPase mechanism of G proteins from the 1.7-Åcrystal structure of transducin- GDP·AlF4-. Nature 1994; 372: 276-79.
95. Coleman DE, Berghuis AM, Lee E, et al. Structures of active conformations of Gil and the mechanism of GTP hydrolysis. Science 1994; 265: 1405-12.
96. Xu YW, Moréra S, Janin J, Cherfils J. AlF3 mimics the transition state of protein phosphorylation in the crystal structure of nucleoside diphosphate kinase and MgADP. Proc Natl Acad Sci USA 1997; 94: 3579-83.
97. Tesmer JJ, Berman DM, Gilman AG, Sprang SR. Structure of RGS4 bound to AlF4-activated Gil: stabilization of the transition state for GTP hydrolysis. Cell 1997; 89: 251-61.
98. Scheffzek K, Ahmadian MR, Kabsch W, et al. Ras-RasGAP communication: Structural basis for GTPase activation and its loss in oncogenic Ras mutants. Science 1997; 277: 333-38.
99. Vincent S, Brouns M, Hart MJ, Settleman J. Evidence for distinct mechanisms of transition state stabilization of GTPases by fluoride. Biochemistry 1998; 95: 2210-15.
100. Klein S, Franco M, Chardin P, Luton F. AlFx affects the formation of focal complexes by stabilizing the Arf-GAP ASAP1 in a complex with Arfl. FEBS Lett 2005; 579: 5741-45.
101. Blaylock RL. Excitotoxicity: A possible central mechanism in fluoride neurotoxicity. Fluoride 2004; 37: 264-77.
102. Chinoy NJ. Studies on fluoride, aluminium and arsenic toxicity in mammals and amelioration by some antidotes. In: Tripathi G Ed, Modern Trends in Environmental Biology. New Delhi, CBS Publishers 2002; 164-96.
103. Shivarajashankara YM, Shivarajashankara AR, Bhat PG, Rao SH. Effect of fluoridation intoxication on lipid peroxidation and antioxidant systems. Fluoride 2001; 34: 108-13.
104. Shivarajashankara YM, Shivarajashankara AR, Bhat PG, Rao SH. Brain lipid peroxidation and antioxidant systems of yound rats in chronic fluoride intoxication. Fluoride 2002; 35: 197-203.
105. Karaoz E, Oncu M, Gulle K, et al. Effect of chronic fluorosis on lipid peroxidation and histology of kidney tissues in first- and second-generation rats. Biol Trace Elem Res 2004; 102: 199-208.
106. Kennedy MB. The postsynaptic density at glutamatergic synapses. Trends Neurosci 1997; 20: 264-68.
107. Gegelashvili G, Dehnes Y, Danbolt NC, Schousboe A. The high-affinity glutamate transporters GLT1, GLAST, and EAAT4 are regulated via different signalling mechanisms. Neurochem Int 2000; 87: 163-70.
108. Tsai VW, Scott HL, Lewis RJ, Dodd PR. The role of group I metabotropic glutamate receptors in neuronal excitotoxicity in Alzheimer's disease. Neurotox Res 2005; 7: 125-41.
109. Seal RP, Amara SG. Excitatory amino acid transporters: a family in flux. Annu Rev Pharmacol Toxicol 1999; 39: 431-56.
110. Trotti D, Danbolt NC, Volterra A. Glutamate transporters are oxidant-vulnerable: a molecular link between oxidative and excitotoxic neurodegeneration? Trends Pharmacol Sci 1998; 19: 328-34.
111. Waxman EA, Lynch DR, N-methyl-D-aspartate receptor subtypes: multiple roles in excitotoxicity and neurological disease. Neuroscientist 2005; 11: 37-49.
112. Springer JE, Azbill RD, Mark RJ, et al. 4-hydroxynonenal, a lipid peroxidation product, rapidly accumulates following traumatic spinal cord injury and inhibits glutamate uptake. J Neurochem 1997; 68: 2469-76.
113. Fain GL, Matthews HR, Cornwall MC, Koutalos Y. Adaptation in vertebrate photoreceptors. Physiol Rev 2001; 81: 117-51.
114. Berridge MJ, Bootman MD, Roderick HL. Calcium signalling: dynamics, homeostasis and remodelling. Nat Rev Mol Cell Biol 2003; 4: 517-29.
115. Berridge MJ, Irvine RF. Inositol trisphosphate, a novel second messenger in cellular signal transduction. Nature 1984; 312: 315-21.
116. Kassner A, Lessmann M, Wasner HK. Degradation of the cyclic AMP antagonist prostaglandylinositol cyclic phosphate (cyclic PIP) by dephosphorylation. Biol Chem 199; 380: 85-88.
117. Weber S, Lemoine H, Wasner HK. Prostaglandin deficiency promotes sensitization of adenylyl cyclase. Biol Chem 2000; 381: 525-29.
118. Scharff O, Foder B. Regulation of cytosolic calcium in blood cells. Physiol Rev 1993; 73: 547-82.
119. Siess W. Multiple signal-transduction pathways synergize in platelet activation. News Physiol Sci 1991; 6: 51-56.
120. Padfield PJ, Panesar N, Henderson P, Baldassare JJ. Differential effects of G-protein activators on 5-hydroxytryptamine and platelet-derived growth factor release from streptolysin-O-permeabilized human platelets. Biochem J 1996; 314: 123-28.
121. Suska M. The effect of sodium fluoride on the adenine nucleotide pool in erythrocytes of Wistar rats. Int J Occup Med Environ Health 2001; 14: 369-73.
122. Cocroft S, Thomas MH. Inositol-lipid-specific phospholipase C isoenzymes and their differential regulation by receptors. Biochem J 1992; 298: 1-14.
123. Maurice DH, Waldo GL, Morris AJ, Nicholas RA, Harden TK. Identification of G alpha 11 as the phospholipase C-activating G-protein of turkey erythrocytes. Biochem J 1993; 290: 765-70.
124. Boyer JL, Waldo GL, Harden TK. Beta gamma-subunit activation of G-protein-regulated phospholipase C. J Biol Chem 1992; 267: 25451-6.
125. Downey GP, Cham CK, Grinstein S. Actin assembly in electropermeabilized neutrophils: role of G-proteins. Biochem Biophys Res Common 1989; 164: 700-05.
126. Bengtsson T, Samdahl E, Stendahl O, Andersson T. Involvement of GTP-binding proteins in actin polymerization in human neutrophils. Proc Natl Acad Sci U S A 1990; 87: 2921-5.
127. Samdahl E, Bokoch GM, Boulay F, Stendahl O, Andersson T. Direct or C5a-induced activation of heterotrimeric Gi2 proteins in human neutrophils is associated with interaction between formyl peptide receptors and the cytoskeleton. J Biol Chem 1996; 271: 15267-71.
128. Zheng L, Eckerdal J, Dimitrijevic I, Andersson T. Chemotactic peptide-induced activation of Ras in human neutrophils is associated with inhibition of p120-GAP activity. J Biol Chem 1997; 272: 23448-54.
129. Conroy LA, Jenkinson EJ, Owen JJ, Michell RH. Phosphatidylinositol 4,5-bisphosphate hydrolysis accompanies T cell receptor-induced apoptosis of murine thymocytes within the thymus. Eur J Immunol 1995; 25: 1828-35.
130. Coggeshall KM, Altman A. Stimulation of PIP2 hydrolysis by aluminium fluoride in resting T cell subsets of normal and autoimmune - prone 1pr mice. J Immunol 1989; 143: 780-86.
131. Cantrell DA, Lucas SC, Word S, Westwick J, Gullberg M. Phorbol esters regulate CD2- and CD3- mediated calcium response in peripheral blood - derived human Tcells. J Immunol 1989; 143: 3653-58.
132. Wong RC, Remold ODE, Vercelli D, et al. Signal transduction via leukocyte antigen CD43 (sialophorin). Feedback regulation by protein kinase C. J Immunol 1990; 144: 1455-60.
133. Loftenius A, Andersson B, Butler J, Ekstrand J. Fluoride augments the mitogenic and antigenic response of human blood lymphocytes in vitro. Caries Res 1999; 33: 148-55.
134. Williams SA, Tappia PS, Yu CH, Bibeau M, Panagia V. Impairment of the sarcolemmal phospholipase D-phosphatidate phosphohydrolase pathway in diabetic cardiomyopathy. J Mol Cell Cardiol 1998; 30: 109-18.
135. Ono K, Arita M. Mechanism of fluoride action on the L-type calcium channel in cardiac ventricular myocytes. Cell Calcium 1999; 26: 37-47.
136. Brown D, Stow JL. Protein trafficking and polarity in kidney epithelium: from cell biology to physiology. Physiol Rev 1996; 76: 245-97.
137. Féraille E, Doucet A. Sodium-potassium-adenosinetriphosphatase-depen-dent sodium transport in the kidney. Physiol Rev 2001; 81: 345-418.
138. Teitelbaum I. The epidermal growth factor receptor is coupled to a phospholipase A2-specific pertussis toxin-inhibitable guanine nucleotide-binding regulatory protein in cultured rat inner medullary collecting tubule cells. J Biol Chem 1990; 265: 4218-22.
139. Refsnes M, Schwarze PE, Holme JA, Lag M. Fluoride-induced apoptosis in human epithelial lung cells (A549 cells): role of different G protein-linked signal systems. Hum Exp Toxicol 2003; 22: 111-23.
140. Lai JC, Blass JP. Inhibition of brain glycolysis by aluminum. J Neurochem 1984; 42: 438-46.
141. Otsuki S, Morshed SR, Chowdhury SA. Possible link between glycolysis and apoptosis induced by sodium fluoride. J Dent Res 2005; 84: 919-23.
142. Greenamyer JT. Neurobioenergetic defects, excitotoxicity and Alzheimer's disease. Neurobiol Aging 1991; 12: 334-36.
143. Gerber U. G-protein-coupled receptors, tyrosine kinases and neurotransmission. Neuropharmacology 2002; 42: 587-92.
144. Gainetdinov RR, Premont RT, Bohn LM, Lefkowitz RJ, Caron MG. Desensitization of G protein-coupled receptors and neuronal functions. Annu Rev Neurosci 2004; 27: 107-44.
145. Rana RS, Hokin LE. Role of phosphoinositides in transmembrane signaling. Physiol Rev 1990; 70: 115-64.
146. Vandenberg RJ, Mitrovic AD, Johnston GA. Molecular basis for differential inhibition of glutamate transporter subtypes by zinc ions. Mol Pharmacol 1998; 54: 189-96.
147. Casado M, Bendahan A, Zafra F, et al. Phosphorylation and modulation of brain glutamate transporters by protein kinase C. J Biol Chem 1993; 268: 27313-17.
148. Qian Y, Galli A, Ramamoorthy S, et al. Protein kinase C activation regulates human serotonin transporters in HEK-293 cells via altered cell surface expression. J Neurosci 1997; 17: 45-57.
149. Beckman ML, Bernstein EM, Quick MW. Multiple G protein-coupled receptors initiate protein kinase C redistribution of GABA transporters in hippocampal neurons. J Neurosci 1999; 19: RC9.
150. Apparsundaram S, Schroeter S, Giovanetti E, Blakely RD. Acute regulation of norepinephrine transport: II. PKC-modulated surface expression of human norepinephrine transporter proteins. J Pharmacol Exp Ther 1998; 287: 744-51.
151. Pristupa ZB, McConkey F, Liu F, et al. Protein kinase-mediated bidirectional trafficking and functional regulation of the human dopamine transporter. Synapse 1998; 30: 79-87.
152. Trotti D, Volterra A, Lehre KP. Arachidonic acid inhibits a purified and reconstituted glutamate transporter directly from the water phase and not via the phospholipid membrane. J Biol Chem 1995; 270: 9890-95.
153. Nakamura Y, Ohmaki M, Yoneda Y. Involvement of protein kinase C in glutamate release from cultured microglial. Brain Res 2003; 962: 122-28.
154. Bonventre JV. Roles of phospholipases A2 in brain cell and tissue injury associated with ischemia and excitotoxicity. J Lipid Mediat Cell Signal 1997; 17: 71-9.
155. Davis KE, Straff DJ, Weinstein EA. Multiple signaling pathways regulate cell surface expression and activity of the excitatory mine acid carrier 1 subtype of Glu transporter in C6 glioma. J Neurosci 1998; 18: 2475-85.
156. Guillet BA, Velly LJ, Canolle B, et al. Differential regulation by protein kinases of activity and cell surface expression of glutamate transporters in neuron-enriched cultures. Neurochem Int 2005; 46: 337-46.
157. Conradt M, Stoffel W. Inhibition of high-affinity brain glutamate transporter GLAST-1 via direct phosphorylation. J Neurochem 1997; 68: 1244-51.
158. Zeevalk GD, Nicklas WJ. Evidence that the loss of the voltage-dependent Mg2+ block at the N-methyl-D-aspartate receptor underlies receptor activation during inhibition of neuronal metabolism. J Neurochem 1992; 59: 1211-20.
159. Chen L, Huang LY. Protein kinase C reduces Mg2+ block of NMDA-receptor channels as a mechanism of modulation. Nature 1992; 356: 521-23.
160. Novelli A, Reilly JA, Lysko PG, Henneberry RC. Glutamate becomes neurotoxic via the N-methyl-D-aspartate receptor when intracellular energy levels are reduced. Brain Res 1988; 451: 205-12.
161. Ogimoto, G, Yudowski GA, Barker CJ. G protein-coupled receptors regulate Na+,K+-ATPase activity and endocytosis by modulating the recruitment of adaptor protein 2 and clathrin. Proc Natl Acad Sci USA 2000; 97: 3242-47.
162. Piet R, Vargova L, Sykova E, Poulain DA, Oliet SH. Physiological contribution of the astrocytic environment of neurons to intersynaptic crosstalk. Proc Natl Acad Sci USA 2004; 101: 2151-5155.
163. Salter MW, Hicks JL. ATP causes release of intracellular Ca2+ via the phospholipase C beta/IP3 pathway in astrocytes from the dorsal spinal cord. J Neurosci 1995; 15: 2961-71.
164. Cazaubon S, Parker PJ, Strosberg AD, Couraud PO. Endothelins stimulate tyrosine phosphorylation and activity of p42/mitogen-activated protein kinase in astrocytes. Biochem J 1993; 293: 381-86.
165. Platt B, Fiddler G, Riedel G, Henderson Z. Aluminium toxicity in the rat brain: histochemical and immunocytochemical evidence. Brain Res Bull 2001; 55: 257-67.
166. Armstrong RA, Winsper SJ, Blair JA. Hypothesis: is Alzheimer's disease a metal-induced immune disorder? Neurodegeneration 1995; 4: 107-11.
167. Pearson VL, Rothwell NJ, Toulmond S. Excitotoxic brain damage in the rat induces interleukin-1beta protein in microglia ands astrocytes: correlation with the progression of cell death. Glia 1999; 25: 311-23.
168. Rothwell NJ. Cytokines-killers in the brain? J Physiol 1999; 514: 3-17.
169. Morimoto K, Murasugi T, Oda T. Acute neuroinflammation exacerbates excitotoxicity in rat hippocampus in vivo. Exp Neurol 2002; 177: 95-104.
170. Eisel ULM BK, Luiten PGM. Life and death of nerve cells: Therapeutic cytokine signaling pathways. Curr Signal Transduction Ther 2006; 1: 133-46.
171. Perry SW, Dewhurst S, Bellizzi MJ, Gelbard HA. Tumor necrosis factor-alpha in normal and diseased brain: Conflicting effects via intraneuronal receptor crosstalk? J Neurovirol 2002; 8: 611-24.
172. Li Y, Liu L, Barger SW, Griffin WS. Interleukin-1 mediates pathological effects of microglia on tau phosphorylation and on synaptophysin synthesis in cortical neurons through a p38-MAPK pathway. J Neurosci 2003; 23: 1605-11.
173. Griffin WST, Sheng JG, Royston MC. Glial-neuronal interactions in Alzheimer's disease: the potential role of a cytokine cycle in disease progression. Brain Pathol 1998; 8: 65-72.
174. Kim SH, Smith CJ, van Eldik L. Importance of MAPK pathways for microglial pro-inflammatory cytokine IL-1β production. Neurobiol Aging 2004; 25: 431-39.
175. Sass JB, Ang LC, Juurlink BHJ. Aluminum pretreatment impairs the ability of astrocytes to protect neurons from glutamate toxicity. Brain Res 1993; 621: 207-14.
176. Allan SM, Rothwell NJ. Cytokines and acute neurodegeneration. Nat Rev Neurosci 2001; 2: 734-44.
177. Refsnes M, Becher R, Lag M, Skuland T, Schwarze PE. Fluoride-induced interleukin-6 and interleukin-8 synthesis in human epithelial lung cells. Hum Exp Toxicol 1999; 18: 645-52.
178. Block F, Dihne M, Loos M. Inflammation in areas of remote changes following focal brain lesion. Prog Neurobiol 2005; 75: 342-65.
179. Budd SL, Tenneti L, Lishnak T, Lipton SA. Mitochondrial and extramitochondrial apoptotic signaling pathways in cerebrocortical neurons. Proc Natl Acad Sci U S A 2000; 97: 6161-6.
180. Nicholls DG, Budd SL, Castilho RF, Ward MW. Glutamate excitotoxicity and neuronal energy metabolism. Am N Y Acad Sci 1999; 893: 1-12.
181. Mercocci P, MacGavrvey U, Kaufman AE, et al. Oxidative damage to mitochondrial DNA shows marked age-dependent increases in human brain. Ann Neurol 1993; 34: 609-16.
182. Candura SM, Castoldi AF, Manzo L, Costa LG. Interaction of aluminum ions with phosphoinositide metabolism in rat cerebral cortical membranes. Life Sci 1991; 49: 1245-52.
183. Candura SM, Castoldi AF, Manzo L, Costa LG. Guanine nucleotide- and muscarinic agonist-dependent phosphoinositide metabolism in synaptoneurosomes from cerebral cortex of immature rats. Neurochem Res 1992; 17: 1133-41.
184. Shafer T, Mundy WR, Tilson HU. Aluminum decreases muscarinic, adrenergic, and metabotropic receptor-stimulated phosphoinositide hydrolysis in hippocampal and cortical slices from rat brain. Brain Res 1993; 629: 133-45.
185. Sarri E, Claro E. Fluoride-induced depletion of polyphosphoinositides in rat brain cortical slices: a rationale for the inhibitory effects on phospholipase C. Int J Develop Neurosci 1989; 17: 357-67.
186. Qian Z, Reddy PV, Drewes LR. Guanine nucleotide-binding protein regulation of microsomal phospholipase D activity of canine cerebral cortex. J Neurochem 1990; 54: 1632-38.
187. Kanfer JN, McCartney D, Singh IN, Freysz L. Phospholipase D activity of
188. Vanecek J. Cellular mechanisms of melatonin action. Physiol Rev 1998; 78: 687-721.
189. Bubis M, Zisapel N. Facilitation and inbibition of G-protein regulated protein secretion by melatonin. Neurochem Int 1995; 27: 177-83.
190. Morgan PJ, Hastings MH, Thompson M, et al. Intracellular signalling: an investigation using aluminium fluoride and melatonin. J Mol Endocrinol 1991; 7: 134-44.
191. Nadakavukaren JJ, Welsh DK, Peppert SM. Aluminium fluoride reveals a phosphoinositide system within the suprachiasmatic region of rat hypothalamus. Brain Res 1990; 507: 181-88.
192. Publicover SJ. Brief exposure to the G-protein activator NaF/AlCl3 induces prolonged enhnacement of synaptic transmission in area CAl of rat hippocampal slices. Exp Brain Res 1991; 84: 680-84.
193. Breakwell NA, Publicover SJ. Characterisation of the role of calcium in AlF4-induced long-term potentiation in area CAl of rat hippocampus. Biosci Rep 1997; 17: 209-18.
194. van der Voet GB, Schijns O, de Wolff FA. Fluoride enhances the effect of aluminium chloride on interconnections between aggregates of hippocampal neurons. Arch Physiol Biochem 1999; 107: 15-21.
195. Chen Y, Penington NJ. Competition between internal AlF4 and receptor-mediated stimulation of dorsal raphe neuron G-proteins coupled to calcium current inhibition. J Neurophysiol 2000; 83: 1273-82.
196. Lau KH, Goodwin C, Arias M, Mohan S, Baylink DJ. Bone cell mitogenic action of fluoroaluminate and aluminum fluoride but not that of sodium fluoride involves upregulation of the insulin-like growth factor system. Bone 2002; 30: 705-11.
197. Komarova SV, Ataullakhanov FI, Globus RK. Bionergetics and mitochondrial transmembrame potential during differentiation of cultured osteoblasts. Am J Physiol Cell Physiol 2000; 279: C1220-29.
198. Zaidi M, Alam AS, Shankar VS, et al. Cellular biology of bone resorption. Biol Rev Camb Philos Soc 1993; 68: 197-264.
199. Selz T, Caverzasio J, Bonjour JP. Fluoride selectively stimulates Na-dependent phosphate transport in osteoblast-like cells. Am J Physiol 1991; 260: E833-38.
200. Sun G, Zhang Y, Sun X. Experimetal study of fluoride toxicity on osteoblasts during bone formation. Fluoride 2005; 38: 254.
201. Zhang Y, Sun G, Jin Y, Wang Y. Effects of fluoride on cell cycle and apoptosis in cultured osteoblasts of rats. Wei Sheng Yan Jiu 2003; 32: 432-33.
202. Okazaki M, Hirata I. Effect of fluoride on the proliferation of osteoblasts. Fluoride 2005; 38: 243.
203. Zhong DB, Sun LT, Wu PF, Su JL, Bo H. Effects of fluoride on proliferation, differentiation, and apoptosis of cultured caprine (goat) osteoblasts. Fluoride 2005; 38: 230-31.
204. Bennett BD, Alvarez U, Hruska KA. Receptor-operated osteoclast calcium sensing. Endocrinology 2001; 142: 1968-74.
205. Rebecchi MJ, Pentyala SN. Structure, function, and control of phosphoinositide-specific phospholipase C. Physiol Rev 2000; 80: 1291-335.
206. Petak I, Houghton JA, Kopper L. Molecular targeting of cell death signal transduction pathways in cancer. Curr Signal Transduction Ther 2006; 1: 113-31.
207. Pan M, Wasa M, Souba WW. Protein kinase C activation inhibits glutamate transport by endothelial cells. J Surg Res 1995; 58: 630-35.
208. Singh K, Ahluwalia P. Studies on the effect of monosodium glutamate [MSG] administration on some antioxidant enzymes in the arterial tissue of adult male mice. J Nutr Sci Vitaminol (Tokyo) 2003; 49: 145-48.
209. Wang P, Verin AD, Birukova A, et al. Mechanism of sodium fluoride-induced endothelial cell barrier dysfunction: role of MLC phosphorylation. Am J Physiol Lung Cell Mol Physiol 2001; 281: L1472-83.
210. Gerritsen ME, Mannix RJ. G-proteins and phospholipase activation in endothelial cells. Adv Exp Med Biol 1990; 275: 115-24.
211. Howell JA, Matthews AD, Swanson KC, Harmon DL, Matthew JC. Molecular identification of high-affinity glutamate transporters in sheep and cattle forestomach, intestine, liver, kidney, and pancreas. J Anim Sci 2001; 79: 1329-36.
212. Boeckhhaebisch EMA, Oliveira RM. Systemic effects of fluoridated water on rats. Arquivos de Biologia e Tecnologia 1997; 40: 57-68.
213. Mullenix PJ, Denbesten PK, Schunior A, Kernan WJ. Neurotoxicity of sodium fluoride in rats. Neurotoxicol Teratol 1995; 17: 169-77.
214. Buzalaf MAR, Fukushima R, Granjeiro JM, Cury JA. Correlation between plasma and nail fluoride concentrations in rats given different levels of fluoride in water. Fluoride 2002; 35: 185-92.
215. Ekambaram P, Paul V. Modulation of fluoride toxicity in rats by calcium carbonate and by withdrawal of fluoride exposure. Pharmacol Toxicol 2002; 90: 53-58.
216. Isaacson RA, Varner JA, Jensen KF. Toxin-induced blood vessel inclusions caused by the chronic administration of aluminum and sodium fluoride and their implications for dementia. Ann NY Acad Sci 1997; 825: 152-66.
217. Varner JA, Jensen KF, Horvath W, Isaacson RL. Chronic administration of aluminum-fluoride or sodium fluoride to rats in drinking water alterations in neuronal and cerebrovascular integrity. Brain Res 1998; 784: 284-98.
218. Inkielewitz I, Krechniak J. Fluoride content in soft tissues and urine of rats exposed to sodium fluoride in drinking water. Fluoride 2003; 36: 263-66.
219. Inkielewicz I, Rogowska M, Krechniak J. Lipid peroxidation and antioxidant enzyme activity in rats exposed to fluoride and ethanol. Fluoride 2006; 39: 53-59.
220. Verma RJ, Guna Sherlin DM. Hypocalcaemia in parental and F1 generation rats treated with sodium fluoride. Food Chem Toxicol 2002; 40: 551-54.
221. Verma RJ, Guna Sherlin DM. Sodium fluoride-induced hypoproteinemia and hypoglycaemia in parental and F1-generation rats and amelioration by vitamins. Food Chem Toxicol 2002; 40: 1781-88.
222. Heard K, Hill RE, Cairns CB, Dart RC. Calcium neutralizes fluoride bioavailability in a lethal model of fluoride poisoning. J Toxicol Clin Toxicol 2001; 39: 349-53.
223. Chinoy NJ, Sharma AK. Reversal of fluoride induced alteration in corda epididymal spermatozoa and fertility impairment in male mice. Environ Sci 1999; 7: 29-38.
224. Bouazis H, Soussia L, Guermazi F, Zeghal N. Fluoride-induced thyroid proliferative changes and their reversal in female mice and their pups. Fluoride 2005; 38: 185-92.
225. Dodam JR, Olson NC. Effect of fluoride on cardiopulmonary function and release of eicosanoids in pigs. J Appl Physiol 1995; 78: 569-77.
226. Zhan XA, Li JX, Xu ZR, Wang M. Effects of fluoride on pancreatic digestive enzyme activities and ultrastructure in young pigs. Fluoride 2005; 38: 215-19.
227. Zhan XA, Wang M, Xu ZR, Li JX. Toxic effects of fluoride on kidney function and histological structure in young pigs. Fluoride 2006; 39: 22-26.
228. Shashi A, Thapar SP. Histopathology of fluoride-induced hepatotoxicity in rabbits. Fluoride 2001; 34: 165-73.
229. Shashi A, Thapar SP. Histopathology of myocardial damage in experimental fluorosis in rabbits. Fluoride 2001; 34: 43-50.
230. Cenesiz S, Ozcan A, Kays N, Baysu N, Karabulut AB. Chronic effects of fluoride in tuj sheep on serum levels of total protein, albumin, uric acid, and nitric oxide and activities of lactate dehydrogenase and leucine aminopeptidase. Fluoride 2005; 38: 52-56.
231. Donmez N, Cinar A. Effects of chronic fluorosis on electrocadiogram in sheep. Toxicol Sci 2003; 72: 363-68.
232. Boink ABTJ, Werner J, Meulenbelt J, Vaesser HAMG, Dewildt DH. The mechanism of fluoride-induced hypocalcaemia. Hum Exp Toxicol 1994; 13: 149-55.
233. Chinoy NJ, Sharma AK. Amelioration of fluoride toxicity by vitamin E and D in reproductive function of male mice. Fluoride 1998; 31: 203-16.
234. Zang ZY, Fan JY, Yen W, et al. The effect of nutrition on the development of endemic osteomalacia in patients with skeletal fluorosis. Fluoride 1996; 29: 20-24.
235. Ge Y, Ning H, Wang S, Wang J. DNA thyroid damage in rats exposed to high F and low iodine. Fluoride 2005; 38: 318-23.
236. Ream LJ, Scott JN, Pendergrass PB. Bone morphology of weanling rats from dams subjected to fluoride. Cell Tissue Res 1983; 233: 689-90.
237. Theuer RC, Mahoney AW, Sarett HP. Placental transfer of fluoride and tin rats given various fluoride and tin salts. J Nutr 1971; 101: 525-32.
238. Collins TF, Sprando RL, Black TN, et al. Developmental toxicity of sodium fluoride in rats. Food Chem Toxicol 1995; 33: 951-60.
239. Bawden JW, Deaton TG, Koch GG, Crawford BP. Effect of an acute maternal fluoride dose on fetal plasma fluoride levels and enamel fluoride uptake in guinea pigs. J Dent Res 1989; 68: 1169-72.
240. Nedeljkovic M, Matovic V. The effect of dose on maternal-foetal transfer of fluoride in rabbits. Arch Hig Rada Toksikol 1991; 42: 43-46.
241. Shupe JL, Bagley CV, Karram MH, Callan RJ. Placental transfer of fluoride in Holstein cows. Vet Human Toxicol 1992; 34: 1-4.
242. Collins TF, Sprando RL, Black TN, et al. Multigenerational evaluation of sodium fluoride in rats. Food Chem Toxicol 2001; 39: 601-13.
243. Collins TF, Sprando RL, Black TN, et al. Developmental toxicity of sodium fluoride measured during multiple generation. Food Chem Toxicol 2001; 39: 867-76.
244. Guna Sherlin DM, Verma RJ, Jacob K. Embryotoxic effects of fluoride on the developing foetus. Indian J Environ Toxicol 1999; 9: 27-29.
245. Heindel JJ, Bates HK, Price CJ, et al. Developmental toxicity evaluation of sodium fluoride administered to rats and rabbits in drinking water. Fundam Appl Toxicol 1996; 30: 162-77.
246. Trabelsi M, Guermazi F, Zeghal N. Effect of fluoride on thyroid function and cerebellar development in mice. Fluoride 2001; 34: 165-73.
247. Skoinick A. New doubts about benefits of sodium fluoride. J Am Med Assoc 1990; 263: 1752-53.
248. Bohatyrewicz A. Effects of fluoride on mechanical properties of femoral bone in growing rats. Fluoride 1999; 32: 47-54.
249. Goh EH, Neff AW. Effects of fluoride on Xenopus embryo development. Food Chem Toicol 2003; 41: 1501-08.
250. Guan ZZ, Wang YN, Xiao KO, et al. Influence of chronic fluorosis on membrane lipids in rat brain. Fluoride 1999; 32: 33-34.
251. Bhatanagar M, Rao P, Jain S, Bhatnagar R. Neurotoxicity of fluoride: Neurodegeneration in hippocampus of female mice. Indian J Exp Biol 2002; 40: 546-54.
252. Chinoy NJ, Shah SD. Sodium fluoride and arsenic trioxide toxicity and its reversal in the brain of mice. Fluoride 2004; 37: 80-7.
253. Sun ZR, Liu FZ, Wu LN. Effects of high fluoride drinking water on the cerebral functions of mice. Chin J Endemiol 2000; 19: 262-63.
254. Shao Q, Wang Y, Guan Z. Influence of free radical inducer on the level of oxidative stress in brain of rats with fluorosis. Chung-Hua Yu Feng J Houch Tsa Chih [Chin J Preventive Med] 2000; 34: 330-32.
255. Shivarajashankara YM, Shivarajashankara AR, Bhat PG, Rao MS, Rao HS. Histological changes in the brain of young fluoride-intoxicated rats. Fluoride 2002; 35: 12-21.
256. Woodbury DM. Maturation of the blood-brain and blood-CSF barriers. In: Vernadakis A, Weiner N Ed, Drugs and the developing brain. New York, Plenum Press 1974; 259-80.
257. Paul V, Ekambaram P, Jayakumar AR. Effects of sodium fluoride on locomotor behavior and a few biochemical parameters in rats. Environ Toxicol Pharmacol 1998; 6: 187-91.
258. Ge Y, Ning H, Wang S, Wang J. Effects of high fluoride and low iodine on brain histopathology in offspring rats. Fluoride 2005; 38: 127-32.
259. Shashi A. Histopathological investigation of fluoride-induced neurotoxicity in rabbits. Fluoride 2003; 36: 95-105.
260. Lu XH, Li GS, Sun B. Study of the mechanism of neuron apoptosis in rats from chronic fluorosis. Chin J Endemiol 2000; 19: 96-98.
261. Burgstahler AW. Paradoxical dose-response effects of fluoride. Fluoride 2002; 35: 143-47.
262. Messer HH, Armstrong WD, Singer L. Influence of fluoride intake on reproduction in mice. J Nutr 1973; 103: 1319-26.
263. Rodríguez Dozal S, Alarcón Herrera MT, Cifuentes E, et al. Dental fluorosis in rural communities of Chihuahua, Mexico. Fluoride 2005; 38: 143-50.
264. Roholm K. Fluorine intoxication, a Clinical Hygienic Study. London, HK Lewis 1937.
265. Waldbott GL, Burgstahler AW, McKinney HL. Fluoridation: the great dilemma. Lawrence, Kansas, Coronado Press 1978; 1-152.
266. Whitford GM. Intake and metabolism of fluoride. Adv Dent Res 1994; 8: 5-14.
267. Pak CYC, Sakhaee K, Gallagher C, et al. Attainment of therapeutic fluoride levels in serum without major side effects using a slow-release preparation of sodium fluoride in postmenopausal osteoporosis. J Bone Miner Res 1986; 1: 563.
268. Kissa E. Determination of inorganic fluoride in blood with a floride ion-selective electrode. Clin Chem 1987; 33: 253-55.
269. Tyler JE, Poole DF, Kong KL. Rapid monitoring of fluoride levels in blood plasma. J Dent 1990; 18: 59-62.
270. Ziegler H, Hauck K, Hefti AF. Fluoride excretion in schoolchildren with differing systemic fluoride care. Schweiz Monatsschr Zahnmed 1991; 101: 1529-34.
271. Xiang QY, Chen LS, Chen XD, et al. Serum fluoride and skeletal fluorosis in two villages in Jiansu Province, China. Fluoride 2005; 38: 178-84.
272. Xiang QY, Liang YX, Chen BH. Serum fluoride and dental fluorosis in two villages in China. Fluoride 2004; 37: 28-37.
273. Susheela AK, Bhatnagar M, Vig K, Mondal NK. Excess fluoride ingestion and thyroid hormone derangements in children living in Delhi, India. Fluoride 2005; 38: 98-108.
274. Oliveby A, Lagerlof F, Ekstrand J, Dawes C. Studies on fluoride excretion in human whole saliva and its relation to flow rate and plasma fluoride levels. Caries Res 1989; 23: 243-46.
275. Toth Z, Ginter Z, Banoczy J. The effect of ingested fluoride administered in salt, milk, and tablets on salivary and urinary fluoride concentrations. Fluoride 2005; 38: 199-204.
276. Wang B, Zheng B, Zhai C, Yu G, Liu X. Relationship between fluorine in drinking water and dental health of residents in some large cities in China. Environ Int 2004; 30: 1067-73.
277. Ron M, Singer L, Menczel J, Kidroni G. Fluoride concentration in amniotic fluid and fetal cord and maternal plasma. Eur J Obstet Gynecol Reprod Biol 1986; 21: 213-18.
278. Chlubek D, Mokrzynski S, Machoy Z, Olszewska M. Fluorides in the body of the mother and in the fetus. III. Fluorides in amniotic fluid. Ginekol Pol 1995; 66: 614-17.
279. Caldera R, Chavinie J, Fermanian J, Tortrat D, Laurent AM. Maternal-fetal transfer of fluoride in pregnant women. Biol Neonat 1988; 54: 263-69.
280. Gupta S, Seth AK, Gupta A, Gavane AG. Transplacental passage of fluorides. J Pediatr 1993; 123: 139-41.
281. Ekstrand J, Hardell LI, Spak CJ. Fluoride balance studies on infants in a 1-ppm-water-fluoride area. Caries Res 1984; 18: 87-92.
282. Koparal E, Ertugrul F, Oztekin K. Fluoride levels in breast milk and infant foods. J Clin Pediatr Dent 2000; 24: 299.
283. Czarnowski W, Krechniak J. Urinary fluoride of schoolchildren in Gdansk, Poland. Fluoride 2002; 35: 239-43.
284. Opydo-Szymaczek J, Borysewicz-Lewicka M. Urinary fluoride levels for assessment of fluoride exposure of pregnant women in Poznan, Poland. Fluoride 2005; 38: 312-17.
285. Huo DY, Yin H. Epidemiological tracking surveys and fluorosis control strategy in Shenyang, China. Fluoride 2005; 38: 233-34.
286. Heller KE, Eklund SA, Burt BA. Dental caries and dental fluorosis at varying water fluoride concentrations. J Public Health Dent 1997; 57: 136-43.
287. McDonagh MS, Whiting PF, Wilson PM, et al. Systematic review of water fluoridation. BMJ 2000; 321: 855-59.
288. Hussain I, Sharma KC. Fluoride distribution and fluorosis in central Rajasthan, India. Fluoride 2005; 38: 235.
289. Meenakshi S, Maheshwari RC. Fluoride in groundwater and prevalence of dental fluorosis among children in villages of Haryana, India. Fluoride 2005; 38: 241.
290. Liang C, Ma F. Effect of fluoride pollution from indoor coal burning on tooth, bone, and blood parameters of farmers in China. Fluoride 2005; 38: 238-39.
291. Reggabi M, Khelfat K, Tabet AM, Azzouz M. Renal function in residents of endemic fluorosis areas in Southern Algeria. Fluoride 1984; 17: 35-41.
292. Kono K, Yoshida Y, Watanabe M. Urinary fluoride excretion in fluoride exposed workers with diminished renal function. Industr Health 1984; 22: 33-40.
293. Warady BA, Koch M, O'Neal DW, et al. Plasma fluoride concentration in infants receiving long-term peritoneal dialysis. J Pediatr 1989; 115: 436-39.
294. Chaleil D, Simon P, Tessier B, Cartier F, Allain P. Blood plasma fluoride in haemodialysed patients. Clin Chim Acta 1986; 156: 105-08.
295. Bello VA, Gitelman HJ. High fluoride exposure in hemodialysis patients. Am J Kidney Dis 1990; 15: 320-4.
296. Arnow PM, Bland LA, Garcia-Houchins S, Fridkin S, Fellner SK. An outbreak of fatal fluoride intoxication in a long-term hemodialysis unit. Ann Intern Med 1994; 121: 339-44.
297. Altmann P, Cunningham J, Dhanesha U, et al. Disturbance of cerebral function in people exposed to drinking water contaminated with aluminium sulphate: retrospective study of the Camelford water incident. BMJ 1999; 319: 807-11.
298. Berend K, van der Voet G, Boer WH. Acute aluminum encephalopathy in a dialysis center caused by a cement mortar water distribution pipe. Kidney Int 2001; 59: 746-53.
299. Conzen PF, Kharasch ED, Czerner SF, et al. Low-flow sevoflurane compared with low-flow isoflurane anesthesia in patients with stable renal insufficiency. Anesthesiology 2002; 97: 578-84.
300. Du L. The effect of fluorine on the developing human brain. Zhonghua Bing Li Xue Za Zhi 1992; 21: 218-20.
301. Li XS, Zhi JL, Gao RO. Effect of fluorine exposure on intelligence in children. Fluoride 1995; 28: 189-92.
302. Zhao LB, Liang GH, Zhang DN, Wu XR. Effect of a high fluoride water supply on children's intelligence. Fluoride 1996; 29: 190-92.
303. Lu Y, Sun ZR, Wu LN, et al. Effect of high fluoride water on intelligence in children. Fluoride 2000; 33: 74-78.
304. Xiang QY, Liang YX, Chen LS, et al. Effect of fluoride in drinking water on intelligence in children. Fluoride 2003; 36: 84-94.
305. Spittle B. Psychopharmacology of fluoride: A review. Clin Psychopharmacol 1994; 9: 79-82.
306. Spittle B. Fluoride and intelligence. Fluoride 2000; 33: 49-52.
307. Exley C. The aluminium-amyloid cascade hypothesis and Alzheimer's disease. Subcell Biochem 2005; 38: 225-34.
308. Verdier Y, Penke B. Polypeptide and protein aggregates with neurotoxic properties in neurodegenerative disorders: Emphasis on beta-amyloid-induced dysfunction of receptor-mediated signal transduction pathways. Curr Signal Transduction Ther 2006; 1: 97-112.
309. Ripova D, Platilova V, Strunecka A, Jirak R, Hoschl C. Cytosolic calcium alterations in platelets of patients with early stages of Alzheimer's disease. Neurobiol Aging 2000; 21: 729-34.
310. Gibson GE, Blass JP, Beal MF, Bunik V. The alpha-ketoglutarate-dehydrogenase complex: a mediator between mitochondria and oxidative stress in neurodegeneration. Mol Neurobiol 2005; 31: 43-63.
311. Huang HM, Zhang H, Xu H, Gibson GE. Inhibition of the alpha-ketoglutarate dehydrogenase complex alters mitochondrial function and cellular calcium regulation. Biochim Biophys Acta 2003; 1637: 119-26.
312. Gibson GE, Huang HM. Oxidative stress in Alzheimer's disease. Neurobiol Aging 2005; 26: 575-78.
313. Luke J. The effect of fluoride on the physiology of the pineal gland. Thesis. Guildford, University of Surrey 1997.
314. Luke J. Fluoride deposition in the aged human pineal gland. Caries Res 2001; 35: 125-28.
315. Illnerová H. Mammalian circadian clock and its resetting. News Physiol Sci 1991; 6: 129-34.
316. Ebadi M, Samejima M, Pfeiffer RF. Pineal gland in synchronizing and refining physiological events. News Physiol Sci 1993; 8: 28-33.
317. Schlesinger ER, Overton DE, Chase HC, Cantwell KT. Newburgh-Kingston caries-fluorine study. XIII. Pediatric findings after ten years. J Am Dent Assoc 1956; 52: 296.
318. Gallerti P. On the use of fluoride to treat overactive thyroid. Fluoride 1976; 9: 105-15.
319. Tezelman S, Shaver JK, Grossman RF, et al. Desensitization of adenylate cyclase in Chinese hamster ovary cells transfected with human thyroid-stimulating hormone receptor. Endocrinology 1994; 134: 1561-69.
320. Bachinskji PP, Gutsalenko OA, Naryzhniuk ND, Sidora VD, Shliakhta AI. [Action of the body fluorine of healthy persons and thyroidopathy patients on the function of hypophyseal-thyroid the system]. Probl Endokrinol (Mosk) 1985; 31: 25-9.
321. Ruiz-Payan A, Duarte-Gardea M, Ortiz MRH. Chronic effects of fluoride on growth, blood chemistry, and thyroid hormones in adolescents residing in three communities in Northern Mexico. Fluoride 2005; 38: 246.
322. Susheela AK, Jethanandani P. Circulating testosterone levels in skeletal fluorosis patients. J Toxicol Clin Toxicol 1996; 34: 183-89.
323. Barot VV. Occurrence of endemic fluorosis in human population of North Gujarat, India: human health risk. Bull Environ Contam Toxicol 1998; 61: 303-10.
324. Freni SC. Exposure to high fluoride concentrations in drinking water is associated with decreased birth rates. J Toxicol Environ Health 1994; 42: 109-21.
325. Liu R, Liu IY, Bi X, et al. Reversal of age related learning deficits and brain oxidative stress in mice with superoxide dismutase/ catalase mimetics. Proc Natl Acad. Sci USA 2003; 128: 15103.
326. Verma RJ, Sherlin DM. Vitamin C ameliorates fluoride-induced embryotoxicity in pregnant rats. Hum Exp Toxicol 2001; 20: 619-23.
327. Guna Sherlin DM, Verma RJ. Amelioration of fluoride-induced hypocalcaemia by vitamins. Hum Exp Toxixol 2000; 19: 632-4.
328. Susheela AK. Fluorosis management programme in India. Curr Sci 1999; 70: 298-304.
329. Nair SB, Jhala DD, Chinoy NJ. Mitigation of genotoxic effects of fluoride and arsenic in human lymphocyte cultures by ascorbic acid. Fluoride 2004; 37: 249-56.
330. Chinoy NJ, Sharma AK, Patel TN, Memon P, Jhala DD. Recovery from fluoride and aluminium induced free radical liver toxicity in mice. Fluoride 2004; 37: 257-63.
331. Kéri G, Orfi L, Ero D. Signal transduction therapy with rationally designed kinase inhibitors. Curr Signal Transduction Ther 2006; 1: 67-95.